4-Substituted proline derivatives that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11.
Analogs of captopril and enalapril with a thiorphan-like substituent at the 4-position of the proline ring were synthesized and found to be dual inhibitors of angiotensin converting enzyme (ACE) and neutral endopeptidase 24.11 (NEP).
References (10)
- et al.
Peptides
(1988) - et al.
- et al.
Pharmacol. Rev.
(1993) - et al.
Trends Pharmacol. Sci.
(1990) - et al.
Med. Res. Rev.
(1985)
There are more references available in the full text version of this article.
Cited by (16)
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome
2017, Bioorganic and Medicinal Chemistry LettersDual inhibition of angiotensin converting enzyme and neutral endopeptidase 24.11
1997, Pharmacochemistry LibraryDiastereoselective synthesis of mixanpril, an orally active dual inhibitor of neutral endopeptidase and angiotensin converting enzyme
1995, Bioorganic and Medicinal Chemistry Lettersα-Mercaptoacyl dipeptides that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11
1995, Bioorganic and Medicinal Chemistry Letters4-Vinylproline
2018, Journal of Organic Chemistry
- 1
Current address: Abbot Laboratories, Neuroscience Research, D4PM, AP10/3, One Abbott Park Road, Abbott Park, IL 60064-3500.
Copyright © 1994 Published by Elsevier Ltd.